Intas Pharmaceuticals

intaspharma.com · Ahmedabad, India

Intas Pharmaceuticals is an Indian multinational pharmaceutical company that develops, manufactures, and markets generic and specialty medicines across therapeutic areas such as oncology, cardiology, neurology, and gastroenterology. It supplies finished dosage formulations and active pharmaceutical ingredients to regulated and emerging markets worldwide, serving hospitals, pharmacies, and healthcare providers. The company generates revenue through the sale of branded and unbranded generics, biosimilars, and contract manufacturing services.

Revenue
$2.2B
Employees
18,000
Founded
1984
Headquarters
Ahmedabad, India

What 6 Arbolus experts think of Intas Pharmaceuticals

NPS scores are uniformly high, with all respondents scoring between 8 and 10, and no detractors in the sample. All experts report an implementation stage of more than one year, demonstrating long-term usage and satisfaction. Renewal intent data is unavailable, but the combination of extended implementation and high NPS implies a low risk of attrition. Key themes include longstanding adoption and high user satisfaction, with no evidence of dissatisfaction or transition risk in the current dataset.Overall Customer Sentiment: Positive

Who reviewed Intas Pharmaceuticals

Total customers 6 6 current · 0 former
Reviews growth +4 in six months
Seniority of respondents
  • C-Suite 83% (5)
  • Manager 17% (1)
Revenue Manager Manager NPS 9
Executive C-Suite NPS 10
Executive C-Suite NPS 8 Will renew

Employer names and spend open once the report publishes.

Tell us when the Intas Pharmaceuticals report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

66 Net Promoter Score, from 6 scored reviews
  • Promoters 4
  • Passives 2
  • Detractors 0

Cumulative NPS by month

-1 over 6 months
  • Jan 10
  • Feb 10
  • Apr 10
  • May 10
  • Jun 9
  • Sep 9

Net Promoter Score across 1 reviews, accumulated up to each month. Category median 66 across 1 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 100%
  • Will renew 1
  • Undecided 0
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 100% 1 answer
  • 8/10 Average score from customers who will renew

For people who use Intas Pharmaceuticals

Do you use Intas Pharmaceuticals at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 6 customers of Intas Pharmaceuticals have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.